Joaquim Bellmunt

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 21

Top Topics

Locally Advanced

Renal Cell Carcinoma

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

British journal of cancer

Nature reviews. Urology

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Anna Hernández-Prat, Alejo Rodriguez-Vida, Laura Cardona, Mengjuan Qin, Oriol Arpí-Llucià, Luis Soria-Jiménez, Sílvia Menendez, Fabricio Gerel Quimis, Miguel Galindo, Edurne Arriola, Marta Salido, Nuria Juanpere-Rodero, Federico Rojo, Aura Muntasell, Joan Albanell, Ana Rovira, Joaquim Bellmunt
Enhancing immunotherapy through PD-L1 upregulation: the promising combination of anti-PD-L1 plus mTOR inhibitors. Molecular oncology (2024)
Matteo Santoni, Hideki Takeshita, Francesco Massari, Aristotelis Bamias, Linda Cerbone, Ondrej Fiala, Veronica Mollica, Sebastiano Buti, Angela Santoni, Joaquim Bellmunt
Pembrolizumab plus enfortumab vedotin in urothelial cancer. Nature reviews. Urology 21 (7) (2024)
Matteo Santoni, Hideki Takeshita, Francesco Massari, Aristotelis Bamias, Linda Cerbone, Ondrej Fiala, Veronica Mollica, Sebastiano Buti, Angela Santoni, Joaquim Bellmunt
Pembrolizumab plus enfortumab vedotin in urothelial cancer. Nature reviews. Urology (2024)
Laura Segalés, Nuria Juanpere-Rodero, Nerea Gallarín, Marta Lorenzo, David López, Júlia Perera-Bel, Alejo Rodriguez-Vida, Lluis Fumadó, Lluís Cecchini, Joaquim Bellmunt, Josep Lloreta-Trull, Silvia Hernández-Llodrà
Immunohistochemical markers as predictors of prognosis in multifocal prostate cancer. Virchows Archiv : an international journal of pathology (2023)
Thomas Powles, Se Hoon Park, Claudia Caserta, Begoña P Valderrama, Howard Gurney, Anders Ullén, Yohann Loriot, Srikala S Sridhar, Cora N Sternberg, Joaquim Bellmunt, Jeanny B Aragon-Ching, Jing Wang, Bo Huang, Robert J Laliberte, Alessandra di Pietro, Petros D Grivas
Avelumab First-Line Maintenance for Advanced Urothelial Carcinoma: Results From the JAVELIN Bladder 100 Trial After ≥2 Years of Follow-Up. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Rosa Nadal, Begoña P Valderrama, Joaquim Bellmunt
Progress in systemic therapy for advanced-stage urothelial carcinoma. Nature reviews. Clinical oncology (2023)
Joep J de Jong, Begoña P Valderrama, Julia Perera, Nuria Juanpere, Paloma Cejas, Henry W Long, M Mar Albà, Ewan A Gibb, Joaquim Bellmunt
Non-muscle-invasive micropapillary bladder cancer has a distinct lncRNA profile associated with unfavorable prognosis. British journal of cancer 127 (2) (2022)
Alejo Rodriguez-Vida, Pablo Maroto, Albert Font, Cristina Martin, Begoña Mellado, Alex Corbera, Mayra Orrillo, Oscar Reig, Rosa Querol, Alejandro Rios-Hoyo, Laia Cano, Judith Alonso, Gemma Martinez, Susana Galtes, Alvaro Taus, Maria Martinez-Garcia, Nuria Juanpere, Oscar Juan, Joaquim Bellmunt
Safety and efficacy of avelumab plus carboplatin in patients with metastatic castration-resistant prostate cancer in an open-label Phase Ib study. British journal of cancer (2022)
Cora N Sternberg, Daniel P Petrylak, Joaquim Bellmunt, Hiroyuki Nishiyama, Andrea Necchi, Howard Gurney, Jae Lyun Lee, Michiel S Van Der Heijden, Eli Rosenbaum, Nicolas Penel, See-Tong Pang, Jian-Ri Li, Xavier García Del Muro Solans, Florence Joly Lobbedez, Zsuzsanna Pápai, Weichao Bao, Peter Ellinghaus, Chengxing Lu, Mitchell Sierecki, Sabine Coppieters, Keiko Nakajima, Tatiane Cristine Ishida, David I Quinn
FORT-1: Phase II/III Study of Rogaratinib Versus Chemotherapy in Patients With Locally Advanced or Metastatic Urothelial Carcinoma Selected Based on FGFR1 / 3 mRNA Expression. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Bhavna Oza, Tim Eisen, Eleni Frangou, Grant D Stewart, Axel Bex, Alastair W S Ritchie, Richard S Kaplan, Benjamin Smith, Ian D Davis, Martin R Stockler, Laurence Albiges, Bernard Escudier, James M G Larkin, Steven Joniau, Barry Hancock, Gregers G Hermann, Joaquim Bellmunt, Mahesh K B Parmar, Patrick Royston, Angela Mary Meade
External Validation of the 2003 Leibovich Prognostic Score in Patients Randomly Assigned to SORCE, an International Phase III Trial of Adjuvant Sorafenib in Renal Cell Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (16) (2022)
Joaquim Bellmunt, Ronald de Wit, Yves Fradet, Miguel A Climent, Daniel P Petrylak, Jae Lyun Lee, Lawrence Fong, Andrea Necchi, Cora N Sternberg, Peter H O'Donnell, Thomas Powles, Elizabeth R Plimack, Dean F Bajorin, Arjun V Balar, Daniel Castellano, Toni K Choueiri, Stephane Culine, Winald R Gerritsen, Howard Gurney, David I Quinn, Jacqueline Vuky, Nicholas J Vogelzang, Razvan Cristescu, Jared Lunceford, Assieh Saadatpour, Andrey Loboda, Junshui Ma, Mohini Rajasagi, James Luke Godwin, Blanca Homet Moreno, Petros D Grivas
Putative Biomarkers of Clinical Benefit With Pembrolizumab in Advanced Urothelial Cancer: Results from the KEYNOTE-045 and KEYNOTE-052 Landmark Trials. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (10) (2022)
Silvia Hernández-Llodrà, Laura Segalés, Nuria Juanpere-Rodero, Tech Marta Lorenzo, Marta Salido, Lara Nonell, Tech David López, Alejo Rodríguez-Vida, Joaquim Bellmunt, Lluís Fumadó, Lluís Cecchini, Josep Lloreta-Trull
SPOP and CHD1 alterations in prostate cancer: Relationship with PTEN loss, tumor grade, perineural infiltration, and PSA recurrence. The Prostate 81 (16) (2021)
Paloma Cejas, Yingtian Xie, Alba Font-Tello, Klothilda Lim, Sudeepa Syamala, Xintao Qiu, Alok K Tewari, Neel Shah, Holly M Nguyen, Radhika A Patel, Lisha Brown, Ilsa Coleman, Wenzel M Hackeng, Lodewijk A A Brosens, Koen M A Dreijerink, Leigh Ellis, Sarah Abou Alaiwi, Ji-Heui Seo, Sylvan Baca, Himisha Beltran, Francesca Khani, Mark Pomerantz, Alessandra Dall'Agnese, Jett Crowdis, Eliezer Van Allen, Joaquim Bellmunt, Colm Morrisey, Peter S Nelson, James A Decaprio, Anna Farago, Nicholas Dyson, Benjamin Drapkin, X Shirley Liu, Matthew L Freedman, Michael C Haffner, Eva Corey, Myles A Brown, Henry W Long
Subtype heterogeneity and epigenetic convergence in neuroendocrine prostate cancer. Nature communications 12 (1) (2021)
Lukas Perkhofer, Talia Golan, Pieter-Jan Cuyle, Tamara Matysiak-Budnik, Jean-Luc Van Laethem, Teresa Macarulla, Estelle Cauchin, Alexander Kleger, Alica K Beutel, Johann Gout, Albrecht Stenzinger, Eric Van Cutsem, Joaquim Bellmunt, Pascal Hammel, Eileen M O'Reilly, Thomas Seufferlein
Targeting DNA Damage Repair Mechanisms in Pancreas Cancer. Cancers 13 (17) (2021)
Thomas Powles, Zoe June Assaf, Nicole Davarpanah, Romain Banchereau, Bernadett E Szabados, Kobe C Yuen, Petros Grivas, Maha Hussain, Stephane Oudard, Jürgen E Gschwend, Peter Albers, Daniel Castellano, Hiroyuki Nishiyama, Siamak Daneshmand, Shruti Sharma, Bernhard G Zimmermann, Himanshu Sethi, Alexey Aleshin, Maurizio Perdicchio, Jingbin Zhang, David S Shames, Viraj Degaonkar, Xiaodong Shen, Corey Carter, Carlos Bais, Joaquim Bellmunt, Sanjeev Mariathasan
ctDNA guiding adjuvant immunotherapy in urothelial carcinoma. Nature 595 (7867) (2021)
Thomas Powles, Srikala S Sridhar, Yohann Loriot, Joaquim Bellmunt, Xinmeng Jasmine Mu, Keith A Ching, Jie Pu, Cora N Sternberg, Daniel P Petrylak, Rosa Tambaro, Louis M Dourthe, Carlos Alvarez-Fernandez, Maureen Aarts, Alessandra di Pietro, Petros D Grivas, Craig B Davis
Avelumab maintenance in advanced urothelial carcinoma: biomarker analysis of the phase 3 JAVELIN Bladder 100 trial. Nature medicine (2021)
Alejo Rodriguez-Vida, Aristotelis Bamias, Emilio Esteban, Maria Isabel Saez, Marta Lopez-Brea, Daniel Castellano, Cristina Caballero, Jose Luis Gonzalez-Larriba, Emiliano Calvo, Sonia Macia, Alain Ravaud, Joaquim Bellmunt
Randomised Phase II study comparing alternating cycles of sunitinib and everolimus vs standard sequential administration in first-line metastatic renal carcinoma (SUNRISES study). BJU international 126 (5) (2020)
Joaquim Bellmunt, Jaegil Kim, Brendan Reardon, Júlia Perera-Bel, Anna Orsola, Alejo Rodriguez-Vida, Stephanie A Wankowicz, Michaela Bowden, Justine A Barletta, Juan Morote, Inés de Torres, Nuria Juanpere, Josep Lloreta-Trull, Silvia Hernandez, Kent W Mouw, Mary-Ellen Taplin, Paloma Cejas, Henry W Long, Eliezer M Van Allen, Gad A Getz, David J Kwiatkowski
Genomic Predictors of Good Outcome, Recurrence, or Progression in High-Grade T1 Non-Muscle-Invasive Bladder Cancer. Cancer research 80 (20) (2020)
Tim Eisen, Eleni Frangou, Bhavna Oza, Alastair W S Ritchie, Benjamin Smith, Richard S Kaplan, Ian D Davis, Martin R Stockler, Laurence Albiges, Bernard Escudier, James M G Larkin, Axel Bex, Steven Joniau, Barry Hancock, Gregers G Hermann, Joaquim Bellmunt, Elizabeth Hodgkinson, Grant D Stewart, Jim Barber, Janet Brown, Rhona McMenemin, Paul Nathan, Lisa M Pickering, Mahesh K B Parmar, Angela Meade
Adjuvant Sorafenib for Renal Cell Carcinoma at Intermediate or High Risk of Relapse: Results From the SORCE Randomized Phase III Intergroup Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 38 (34) (2020)
Abhishek Tripathi, Jeffrey G Supko, Kathryn P Gray, Zachary J Melnick, Meredith M Regan, Mary-Ellen Taplin, Atish D Choudhury, Mark M Pomerantz, Joaquim Bellmunt, Channing Yu, Zijie Sun, Sandy Srinivas, Philip W Kantoff, Christopher J Sweeney, Lauren C Harshman
Dual Blockade of c-MET and the Androgen Receptor in Metastatic Castration-resistant Prostate Cancer: A Phase I Study of Concurrent Enzalutamide and Crizotinib. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (23) (2020)
Joaquim Bellmunt, Aly-Khan A Lalani, Sussana Jacobus, Stephanie A Wankowicz, Laura Polacek, David Y Takeda, Lauren C Harshman, Nikhil Wagle, Irene Moreno, Kevin Lundgren, Dominick Bossé, Eliezer M Van Allen, Toni K Choueiri, Jonathan E Rosenberg
Everolimus and pazopanib (E/P) benefit genomically selected patients with metastatic urothelial carcinoma. British journal of cancer 119 (6) (2018)